
Navrit Pharmaceutical Private Limited
About Navrit Pharmaceutical Private Limited
Data last updated:
Navrit Pharmaceutical Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51900HR2018PTC077072. Its GSTIN is 02AAGCN2992R1ZV (Himachal Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Devender Dogra and Abhinav Dogra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18 Ff Augusta Point Golf Course Road Sector 53, Gurgaon, Haryana, India – 122002.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.23 Lakh, a decline of 47% compared to the previous year. For the same year it recorded a net loss of ₹10,731 (net margin -0.6%) and EBITDA of -₹10,731 (EBITDA margin -0.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 50% over five years.
Company details
Contact details
Navrit Pharmaceutical Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address is in the company report.
- Email
- Registered Address18 Ff Augusta Point Golf Course Road Sector 53, Gurgaon, Haryana, India – 122002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Navrit Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Navrit Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Navrit Pharmaceutical Private Limited, buy the company report.
Financials of Navrit Pharmaceutical Private Limited
FY 2025 filings availableNavrit Pharmaceutical Private Limited reported revenue of ₹17.23 Lakh (down 47% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 47% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 50%. EBITDA fell 127% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10,731 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10,731 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.6% | ||||
| Net Profit Margin | -0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Navrit Pharmaceutical Private Limited, buy the company report.
Board of directors of Navrit Pharmaceutical Private Limited
Navrit Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devender Dogra Also directs: Seagull Laboratories (India) Private Limited | Director | 27 Nov 2018 | 7 Years 11 Months | Current |
| Abhinav Dogra Also directs: Seagull Laboratories (India) Private Limited | Director | 27 Nov 2018 | 7 Years 11 Months | Current |
Peer comparison
Navrit Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mitranirmal Meditech Private Limited | ₹17.27 Lakh (FY 2025) | -28.0% | Nachane, Maharashtra, India | |||
| SMN Pharma Private Limited | ₹17.27 Lakh (FY 2025) | 393.0% | Chennai, Tamil Nadu, India | |||
| Modern Health Products Private Limited | ₹17.26 Lakh (FY 2025) | 80.0% | Gwalior, Madhya Pradesh, India | |||
| Zipka Pharmaceuticals Private Limited | ₹17.24 Lakh (FY 2024) | 429.0% | Lucknow, Uttar Pradesh, India | |||
| Shreejee Adhesives & Glue Private Limited | ₹17.24 Lakh (FY 2024) | -9.0% | Noida, Uttar Pradesh, India | |||
| Navrit Pharmaceutical Private Limitedthis company | ₹17.23 Lakh (FY 2025) | -₹10,731 | -0.6% | -47.0% | Gurgaon, Haryana, India | |
| Bangalore Hemp Private Limited | ₹17.2 Lakh (FY 2023) | 379.0% | Bangalore, Karnataka, India | |||
| Ivna Bioenergy Private Limited | ₹17.2 Lakh (FY 2024) | 129.0% | Pune, Maharashtra, India | |||
| Kamsons Pharmaceuticals Private Limited | ₹17.19 Lakh (FY 2019) | -35.0% | Ahmedabad, Gujarat, India | |||
| Wallerich Life Sciences Private Limited | ₹17.19 Lakh (FY 2022) | 33.0% | Halasuru, Karnataka, India | |||
| Maverick Pharma Private Limited | ₹17.17 Lakh (FY 2025) | -72.0% | Delhi, India |
To see the full peer comparison of Navrit Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Navrit Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Navrit Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Navrit Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAGCN2992R1ZV | Himachal Pradesh | Active | 03 Jul 2019 |
To see the full GST registrations and return filing status of Navrit Pharmaceutical Private Limited, buy the company report.
Recent activity
Navrit Pharmaceutical Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Abhinav Dogra was appointed as Director on 27 Nov 2018.
Frequently asked questions
Navrit Pharmaceutical is an active private limited company based in Gurgaon, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 November 2018 (8+ years old) and is registered under CIN U51900HR2018PTC077072.
Navrit Pharmaceutical has 2 current directors:
- Devender Dogra - Director
- Abhinav Dogra - Director
The latest financial statements of Navrit Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Navrit Pharmaceutical is 02AAGCN2992R1ZV, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Navrit Pharmaceutical is U51900HR2018PTC077072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Navrit Pharmaceutical was incorporated on 27 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Navrit Pharmaceutical by revenue are Mitranirmal Meditech Private Limited, SMN Pharma Private Limited, Modern Health Products Private Limited, Zipka Pharmaceuticals Private Limited, Shreejee Adhesives & Glue Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Abhinav Dogra was appointed as Director on 27 Nov 2018. Devender Dogra was appointed as Director on 27 Nov 2018.
The registered office of Navrit Pharmaceutical is at 18 Ff Augusta Point Golf Course Road Sector 53, Gurgaon, Haryana, India – 122002.
Navrit Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Navrit Pharmaceutical can be reached at its registered office: 18 Ff Augusta Point Golf Course Road Sector 53, Gurgaon, Haryana, India – 122002.

